OncoCyte Corp (NASDAQ:OCX)

0.7499
Delayed Data
As of Sep 30
 +0.0099 / +1.34%
Today’s Change
0.68
Today|||52-Week Range
3.73
-65.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$94.9M

Company Description

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Contact Information

OncoCyte Corp.
15 Cushing
Irvine California 92618
P:(949) 409-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders60.50%
Other institutional50.26%
Mutual fund holders5.84%

Top Executives

Ronald Asbury AndrewsChief Executive Officer & Director
Gisela PaulsenPresident & Chief Operating Officer
Anish JohnChief Financial Officer & Senior Vice President
Douglas T. RossChief Science Officer
Ekkehard SchützChief Technology Officer